London, United Kingdom

Andrew W Claxson

This inventor holds 1 USPTO granted patent. Top assignee: British Technology Group Limited. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew W Claxson. Retrieved from https://idiyas.com/inventor/andrew-w-claxson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrew W. Claxson

Introduction

Andrew W. Claxson is a notable inventor based in London, GB. He has made significant contributions to the field of medical technology, particularly in the treatment of retinopathy of prematurity. His innovative work has led to the development of a patent that addresses this critical health issue.

Latest Patents

Andrew W. Claxson holds a patent for the "Treatment and inhibition of retinopathy of prematurity." This patent represents a significant advancement in medical treatments aimed at improving the health outcomes of premature infants.

Career Highlights

Claxson is associated with the British Technology Group Limited, where he has been instrumental in driving forward innovative solutions in technology and healthcare. His work has garnered attention for its potential impact on neonatal care.

Collaborations

Throughout his career, Andrew has collaborated with esteemed colleagues such as Peter A. Good and Christopher J. Morris. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Andrew W. Claxson's contributions to medical technology through his patent and collaborative efforts highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in the treatment of critical health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…